FDA Inspection 1119769 - OMRIX Biopharmaceuticals Ltd - March 05, 2020

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns OMRIX Biopharmaceuticals Ltd, with an inspection on March 5, 2020, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: OMRIX Biopharmaceuticals Ltd
Inspection Date: March 5, 2020
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · b50be1e1-56d6-4eaf-ace7-7def5cf61613

Violation Codes4

21 CFR 211.160(a)21 CFR 211.160(b)21 CFR 211.188(b)(8)21 CFR 211.194(a)(4)

Full citation text and observation details available on the Dashboard.